← Back to directory

Daniel Olive

Researcher Next ID · RN-032696

Researcher · Immunology and Microbiology

Centre National de la Recherche Scientifique

Paris, France

Accepting doctoral researchersFunding unknown
Works count
1,062
Citation count
26,533
H-index
83
i10-index
348

Research interests

Immunology and Microbiology
Medicine
Immune Cell Function and Interaction
Cancer Immunotherapy and Biomarkers
Immunotherapy and Immune Responses
CAR-T cell therapy research
T-cell and B-cell Immunology

Publications

  • Major pathways involved in macrophage polarization in cancer

    Frontiers in Immunology · 2022 · 10.3389/fimmu.2022.1026954

  • Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis

    The Journal of Infectious Diseases · 2021 · 10.1093/infdis/jiab044

  • Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment

    Frontiers in Immunology · 2018 · https://doi.org/10.3389/fimmu.2018.01044

  • Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization

    Journal of Allergy and Clinical Immunology · 2016 · 10.1016/j.jaci.2016.04.025

  • Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity

    Cancer Research · 2016 · 10.1158/0008-5472.can-15-1965

  • PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma

    Oncotarget · 2016 · 10.18632/oncotarget.12150

  • Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer

    Oncotarget · 2015 · 10.18632/oncotarget.3965

  • Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti–PD-L1 Antibodies

    Cancer Research · 2015 · https://doi.org/10.1158/0008-5472.can-14-3477

  • A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission

    Blood · 2012 · https://doi.org/10.1182/blood-2012-06-437558

  • PD-1–Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer

    Cancer Research · 2012 · https://doi.org/10.1158/0008-5472.can-12-2606

  • Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset

    Blood · 2012 · https://doi.org/10.1182/blood-2012-05-430470

  • PD-1 is a novel regulator of human B-cell activation

    International Immunology · 2012 · 10.1093/intimm/dxs098

  • ICOS-Ligand Expression on Plasmacytoid Dendritic Cells Supports Breast Cancer Progression by Promoting the Accumulation of Immunosuppressive CD4+ T Cells

    Cancer Research · 2012 · 10.1158/0008-5472.can-12-2409

  • CD8+ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1

    Cancer Research · 2011 · 10.1158/0008-5472.can-11-2637

  • Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

    Journal of Clinical Investigation · 2011 · https://doi.org/10.1172/jci45816

  • BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination

    Journal of Clinical Investigation · 2010 · https://doi.org/10.1172/jci40070

  • Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome

    Cancer Research · 2009 · https://doi.org/10.1158/0008-5472.can-08-2360

  • CpG Methylation Controls Reactivation of HIV from Latency

    PLoS Pathogens · 2009 · 10.1371/journal.ppat.1000554

  • Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation

    Nature Chemical Biology · 2008 · 10.1038/nchembio.103

  • Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome

    Blood · 2008 · https://doi.org/10.1182/blood-2008-07-168096

  • CD8+CD28− T Regulatory Lymphocytes Inhibiting T Cell Proliferative and Cytotoxic Functions Infiltrate Human Cancers

    The Journal of Immunology · 2007 · https://doi.org/10.4049/jimmunol.179.7.4323

  • Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction

    Blood · 2006 · 10.1182/blood-2005-08-027979

  • IFN-α Skews Monocyte Differentiation into Toll-Like Receptor 7-Expressing Dendritic Cells with Potent Functional Activities

    The Journal of Immunology · 2003 · 10.4049/jimmunol.171.7.3385

  • Defective expression and function of natural killer cell–triggering receptors in patients with acute myeloid leukemia

    Blood · 2002 · https://doi.org/10.1182/blood.v99.10.3661

  • Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.

    PubMed · 2000

  • Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling

    Nature · 1994 · 10.1038/369327a0

Current projects

    No projects listed.